Online Poster Portal

  • Author
    Hanning Xing
  • Co-author

    Christian D. Seger, Libing Wang, John S. Shin

  • Title

    Intraoperative Diagnosis of SGLT-2 Inhibitor Associated Euglycemic Diabetic Ketoacidosis, a Case Report

  • Abstract

    The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is increasingly common in type
    2 diabetes mellitus (DM) management. Patients taking an SGLT2 inhibitor are at increased risk for euglycemic
    diabetic ketoacidosis (EDKA). We report an intraoperative diagnosis of EDKA in a patient taking an SGLT2 inhibitor. The
    patient was found to have an arterial pH of 7.21 and serum beta-hydroxybutyrate of 88.8 mg/
    dL (normal: <3.0 mg/dL) with serum glucose <250 mg/dL. Acidosis resolved with insulin and
    glucose infusions. Perioperative specialists must recognize the potential for EDKA in patients
    taking SGLT2 inhibitors. Expert opinion suggests preoperative cessation for 2–3 days and
    intraoperative serum ketone concentration measurement for at-risk patients.

  • College


  • Zoom

  • PDF